Navigation Links
UT Arlington's Nguyen named American Heart Association fellow
Date:11/20/2013

Associate bioengineering professor Kytai Nguyen has been elected as a fellow of the American Heart Association, an honor conferred by the national organization's Council on Basic Cardiovascular Sciences.

Nguyen, who joined The University of Texas at Arlington in 2005, specializes in cellular engineering. Her research also involves tissue engineering, drug delivery and stem cell therapies.

Liping Tang, interim chairman of the UT Bioengineering Department, nominated Nguyen and said her work helps build healthier lives and offers patients who battle cardiovascular disease a better quality of life.

"Her projects help us to understand factors in the development of cardiovascular diseases, including atherosclerosis and restenosis so that better strategies to combat these diseases could be developed," Tang said.

Nguyen currently is working with the American Heart Association on a new method that would use injected nanoparticles to recruit stem cells from a patient's own blood to build stents needed in that patient's failing blood vessels.

In another project, Nguyen is working with UT Southwestern researchers to develop a nanoparticle drug delivery system.

Nguyen also was the recipient of the Scientist Development Award from the National American Heart Association in 2007.

Nguyen's work is representative of research excellence at The University of Texas at Arlington, a comprehensive institution of more than 33,300 students and 2,200 faculty members in the heart of North Texas. Visit http://www.uta.edu to learn more.


'/>"/>

Contact: Herb Booth
hbooth@uta.edu
817-272-7075
University of Texas at Arlington
Source:Eurekalert  

Page: 1

Related biology news :

1. AlloSource Named One Of Colorados Top Bioscience Companies Of The Year
2. Winners named in 2013 AAAS Kavli Science Journalism Awards competition
3. Walgreens Mike Ellis Named First President of National Association of Specialty Pharmacy (NASP)
4. AnaptysBio Named a 2013 "Fierce 15" Winner
5. Beaumont named to 2013 InformationWeek 500 list of top technology innovators
6. Dr. Paul J. Reilly, MD, FAAFP, is Named Strax Rejuvenations Doctor of the Month for August
7. Helper cells aptly named in battle with invading pathogens
8. Tufts Engineer Qiaobing Xu named 2013 Pew Scholar
9. TGens Huentelman and Weiss named to 2013 Class of 40 Under 40
10. NYU Langone Medical Center researcher named Howard Hughes Investigator
11. St. Jude scientist named Howard Hughes Medical Institute investigator
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UT Arlington's Nguyen named American Heart Association fellow
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:11/14/2016)... SANTA CLARA, Calif. , Nov. 14, ... of the biometric identification market, Frost & ... Global Frost & Sullivan Award for Visionary ... leading player in the biometric identification market ... a multi-modal verification solution for instant, seamless, ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , ... December 08, 2016 , ... ... in the World Technology Awards. uBiome is one of just six company finalists ... categories. , In addition to uBiome, companies nominated as finalists in this year’s ...
(Date:12/8/2016)... 8, 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... on developing and commercializing products to treat rare ... announced today the long-term follow-up data from its ... first-in-class Innate Defense Regulator (IDR), in the treatment ... cancer patients undergoing chemoradiation therapy (CRT).  The additional ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/8/2016)... Korea , Dec. 8, 2016 Eutilex ... $21 billion KRW (US $18.9M) Series A financing. This ... Investment, G.N. Tech Venture and SNU Bio Angel. This ... to 30.5 billion KRW (US $27.7M) since its founding ... Eutilex to bolster the development and commercialization of its ...
Breaking Biology Technology: